These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 365123)
41. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose. Castellanos FX; Giedd JN; Elia J; Marsh WL; Ritchie GF; Hamburger SD; Rapoport JL J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):589-96. PubMed ID: 9136492 [TBL] [Abstract][Full Text] [Related]
42. Dextroamphetamine and methylphenidate in the treatment of hyperactive-aggressive children. Winsberg BG; Press M; Bialer I; Kupietz S Pediatrics; 1974 Feb; 53(2):236-41. PubMed ID: 4590730 [No Abstract] [Full Text] [Related]
43. The effect of stimulant medication on academic performance, in the context of multimodal treatment, in attention deficit disorders with hyperactivity: two case reports. Schmidt K; Solanto MV; Sanchez-Kappraff M; Vargas P; Wein S J Clin Psychopharmacol; 1984 Apr; 4(2):100-3. PubMed ID: 6707235 [TBL] [Abstract][Full Text] [Related]
44. Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial. Efron D; Jarman F; Barker M Pediatrics; 1997 Dec; 100(6):E6. PubMed ID: 9382907 [TBL] [Abstract][Full Text] [Related]
45. Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Nolan EE; Gadow KD; Sprafkin J Pediatrics; 1999 Apr; 103(4 Pt 1):730-7. PubMed ID: 10103294 [TBL] [Abstract][Full Text] [Related]
46. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Stein MA; Sarampote CS; Waldman ID; Robb AS; Conlon C; Pearl PL; Black DO; Seymour KE; Newcorn JH Pediatrics; 2003 Nov; 112(5):e404. PubMed ID: 14595084 [TBL] [Abstract][Full Text] [Related]
47. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder. Pelham WE; Aronoff HR; Midlam JK; Shapiro CJ; Gnagy EM; Chronis AM; Onyango AN; Forehand G; Nguyen A; Waxmonsky J Pediatrics; 1999 Apr; 103(4):e43. PubMed ID: 10103335 [TBL] [Abstract][Full Text] [Related]
48. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study. Firestone P; Musten LM; Pisterman S; Mercer J; Bennett S J Child Adolesc Psychopharmacol; 1998; 8(1):13-25. PubMed ID: 9639076 [TBL] [Abstract][Full Text] [Related]
49. The effects of caffeine and methylphenidate on hyperactive children. Firestone P; Davey J; Goodman JT; Peters S J Am Acad Child Psychiatry; 1978; 17(3):445-56. PubMed ID: 690354 [No Abstract] [Full Text] [Related]
50. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction. Conners CK Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496 [No Abstract] [Full Text] [Related]
51. Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder. Castellanos FX; Elia J; Kruesi MJ; Marsh WL; Gulotta CS; Potter WZ; Ritchie GF; Hamburger SD; Rapoport JL Neuropsychopharmacology; 1996 Feb; 14(2):125-37. PubMed ID: 8822535 [TBL] [Abstract][Full Text] [Related]
52. Ineffectiveness of imipramine in children who fail to respond to methylphenidate. Winsberg BG; Kupietz SS; Yepes LE; Goldstein S J Autism Dev Disord; 1980 Jun; 10(2):129-37. PubMed ID: 6765502 [TBL] [Abstract][Full Text] [Related]
53. Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. Barrickman LL; Perry PJ; Allen AJ; Kuperman S; Arndt SV; Herrmann KJ; Schumacher E J Am Acad Child Adolesc Psychiatry; 1995 May; 34(5):649-57. PubMed ID: 7775360 [TBL] [Abstract][Full Text] [Related]
55. Methylphenidate v. placebo--a randomised double-blind crossover study in children with the attention deficit disorder. Cotton MF; Rothberg AD S Afr Med J; 1988 Sep; 74(6):268-71. PubMed ID: 3047886 [TBL] [Abstract][Full Text] [Related]
56. Changes in the electroencephalogram accompanying the use of stimulant drugs (methylphenidate and dextroamphetamine) in hyperactive children. Surwillo WW Biol Psychiatry; 1977 Dec; 12(6):787-99. PubMed ID: 597528 [TBL] [Abstract][Full Text] [Related]
57. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study). Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ; Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578 [TBL] [Abstract][Full Text] [Related]
58. An individual double-blind crossover trial for assessing methylphenidate response in children with attention deficit disorder. McBride MC J Pediatr; 1988 Jul; 113(1 Pt 1):137-45. PubMed ID: 3290413 [TBL] [Abstract][Full Text] [Related]